Trial Profile

Phase 1b safety and immunogenicity study of a universal flu vaccine

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Apr 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza virus vaccine (Primary) ; Influenza A virus DNA vaccine-H5N1; Influenza A virus vaccine-H5N1
Indications Influenza virus infections
Focus Adverse reactions

Most Recent Events

10 Dec 2010 Results to be reported at the World Health Organization 7th Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials, according to a Dynavax media release.
27 Sep 2010 New trial record
23 Sep 2010 Preliminary data is expected to be available in early 2011, and subjects will continue to be monitored for a further year, according to a Dynavax Technologies media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com